Related Experiment Video

Updated: Jun 20, 2026

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents

Ziyun Du1, Meiyun Fan1, Jong-Gwan Kim1

  • 1Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center and Center for Cancer Research, Memphis, Tennessee 38163.

The Journal of Biological Chemistry
|August 19, 2009
PubMed

Insights

Interferon-alpha (IFNalpha) resistance in cancer cells is linked to a lack of STAT2 protein. Restoring STAT2 expression re-sensitized cells to both IFNalpha and chemotherapy-induced apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferon-alpha (IFNalpha) shows therapeutic potential in cancer treatment.
  • Development of resistance to IFNalpha is a major clinical challenge.
  • Understanding mechanisms of IFNalpha resistance is crucial for improving cancer therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying IFNalpha resistance in cancer cells.
  • To explore the role of STAT2 protein in IFNalpha sensitivity and chemotherapy-induced apoptosis.
  • To identify potential therapeutic strategies for overcoming IFNalpha and chemoresistance.

Main Methods:

  • Isolation and characterization of an IFNalpha-resistant cell line (RST2) from a sensitive cell line (Daudi).
  • Analysis of STAT2 mRNA and protein expression in sensitive and resistant cell lines.
  • Functional rescue experiments involving STAT2 re-expression in RST2 cells.
  • Assessment of cellular responses to IFNalpha and chemotherapeutic agents (camptothecin, staurosporine, doxorubicin).

Main Results:

  • The RST2 cell line exhibited resistance to IFNalpha's antiviral, antiproliferative, and gene-induction effects.
  • RST2 cells showed deficient STAT2 protein expression despite the presence of STAT2 mRNA.
  • A specific variant STAT2 mRNA resulting from alternative splicing was highly expressed in RST2 cells.
  • RST2 cells demonstrated intrinsic resistance to apoptosis induced by multiple chemotherapeutic agents.
  • Re-expression of STAT2 in RST2 cells restored sensitivity to both IFNalpha and chemotherapy-induced apoptosis.

Conclusions:

  • STAT2 deficiency is a key factor in IFNalpha resistance and intrinsic chemoresistance.
  • STAT2 plays a critical role in mediating cellular responses to IFNalpha and chemotherapy-induced apoptosis.
  • Targeting STAT2 may offer a novel strategy to overcome resistance to both IFNalpha and conventional chemotherapies in cancer treatment.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...